- Home
- BBIO vs PNW Comparison
BBIO vs PNW Comparison
Compare BBIO & PNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BBIO | PNW |
|---|---|---|
| Founded | 2015 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7B | 11.1B |
| IPO Year | 2019 | 1994 |
Fundamental Metrics
Financial Performance| Metric | BBIO | PNW |
|---|---|---|
| Price | $69.97 | $106.41 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 25 | 15 |
| Target Price | $86.33 | ★ $100.21 |
| AVG Volume (30 Days) | ★ 2.7M | 1.0M |
| Earning Date | 05-12-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 3.58% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.27 |
| Revenue | $502,076,000.00 | ★ $5,339,939,000.00 |
| Revenue This Year | $89.45 | $5.15 |
| Revenue Next Year | $73.78 | $6.89 |
| P/E Ratio | ★ N/A | $390.19 |
| Revenue Growth | ★ 126.26 | 4.20 |
| 52 Week Low | $41.80 | $85.32 |
| 52 Week High | $84.94 | $105.62 |
Technical Indicators
Market Signals| Indicator | BBIO | PNW |
|---|---|---|
| Relative Strength Index (RSI) | 56.93 | 65.39 |
| Support Level | $62.94 | $86.28 |
| Resistance Level | $71.74 | N/A |
| Average True Range (ATR) | 2.24 | 1.86 |
| MACD | 0.44 | 0.39 |
| Stochastic Oscillator | 84.55 | 93.16 |
Price Performance
Historical ComparisonAbout BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About PNW Pinnacle West Capital Corporation
Pinnacle West is a holding company whose principal subsidiary is Arizona Public Service, a vertically integrated electric utility serving approximately 1.4 million customers across a 35,000-square-mile territory in central Arizona, including the Phoenix area. APS owns or leases 6.5 gigawatts of power generation capacity, including a 29% ownership stake in one of the largest nuclear plants in the US, Palo Verde. Half of the electricity that APS supplies to customers comes from clean energy sources, including nuclear.